Impact of pscyhoimmunology in research at major psychoses

Michael Maes; Amy Lin; Carlo Altamura; Herbert Y. Meltzer; E. Bosmans; Rint de Jong; Günter Kenis

doi:10.1016/s0006-3223(97)88113-9

Article1993

Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?

Raymond J. Dolan, C.J. Bench, Peter F. Liddle, Karl Friston, Chris Frith, Paul M. Grasby, R. S. J. Frackowiak

Article2020

The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses

Sílvia Amoretti, Adriane Ribeiro Rosa, Gisela Mezquida, Bibiana Cabrera, María Ribeiro, María Dolores Molina Vila, Miquel Bioque, António Lobo, Ana González‐Pinto, David Fraguas, Iluminada Corripio, Eduard Vieta, Elena de la Serna, Laura Morro, Marina Garriga, Carla Torrent, Manuel J. Cuesta, Miquel Bernardo

Article2016

The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study

Sílvia Amoretti, Miquel Bernardo, Caterina del Mar Bonnín, Miquel Bioque, Bibiana Cabrera, Gisela Mezquida, Brisa Solé, Eduard Vieta, Carla Torrent

Article2008

Nanomaterials at work in biomedical research

Younan Xia

Article1994

Prescription patterns in hospitalized patients with refractory psychoses

John Roy, Germain Chouinard, Mark S. Tremblay, C. Damecours

Biological Psychiatry

Impact of pscyhoimmunology in research at major psychoses

Discussion(0)

Related publications

Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity?

The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses

The impact of cognitive reserve in the outcome of first-episode psychoses: 2-year follow-up study

Nanomaterials at work in biomedical research

Prescription patterns in hospitalized patients with refractory psychoses